Watch These Novo Nordisk Stock Price Levels After Last Week’s 33% Drop
Key Takeaways
- Novo Nordisk’s U.S.-listed shares were slightly higher in recent trading after shedding a third of their value last week, when the company cut its full-year outlook and named a new CEO.
- The shares had resumed their steep downtrend last week on above-average volume, indicating selling conviction from larger market participants.
- Investors should watch major support levels on Novo Nordisk’s chart around $36 and $29, while also monitoring key overhead areas near $60 and $78.
Novo Nordisk’s (NVO) U.S.-listed shares were up about 2% in recent trading after shedding about a third of their value last week, when the company cut its full-year outlook and named a new CEO, leading Wall Street analysts to downgrade the stock.
Since…
